Compulsory licences now available for export of patented pharmaceuticals

  As of 25 August 2015, it is now possible for third parties to apply to the Federal Court of Australia for a compulsory licence to manufacture generic versions of patented pharmaceutical inventions (“PPI”) for export to developing countries to address public health problems.   Background Australia is a signatory to the World Trade Organization